5433.0000 -75.00 (-1.36%)
NSE Sep 26, 2025 15:31 PM
Volume: 181.5K
 

5433.00
-1.36%
Axis Direct
Alkem's domestic formulations business (76% of sales) grew 15% YoY (grew 22% YoY adj for excise duty impact, realization gap under GST) led by channel restocking. Gross margin improved 118 bps YoY, while EBITDA margin improved 574 bps driven by operating leverage.
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended